StockWatch
·
HomeLiveWeekly
Pharmaceutical Preparations
DelistingJul 16, 2026, 05:06 PM

ZyVersa Therapeutics Moves to OTC Pink Limited Market

AI Summary

ZyVersa Therapeutics, Inc. announced that effective July 16, 2026, its common stock ceased trading on the OTCQB Venture Market. Concurrently, the company's shares began trading on the OTC Pink Limited Market. This move typically indicates a downgrade in market tier.

Key Highlights

  • ZyVersa Therapeutics, Inc. ceased trading on the OTCQB Venture Market.
  • The company commenced trading on the OTC Pink Limited Market.
  • The change was effective July 16, 2026.
View SEC Filing
ZVSA
Pharmaceutical Preparations
ZyVersa Therapeutics, Inc.

Price Impact

More from ZVSA

RestructuringJul 10, 4:33 PM

ZyVersa Therapeutics Explores Cost Cuts, Divestments, & 'Going Dark'

Quarterly ResultMay 13, 4:52 PM

ZyVersa Q1 Net Loss $(1.79)M; Going Concern Doubt Raised

More in Delisting

OBAI1h ago

Our Bond Receives Nasdaq Delisting Notices for Non-Compliance

CYCU2h ago

Cycurion Receives Nasdaq Delisting Notice; Plans Appeal

SRXH8h ago

SRX Global back in compliance with NYSE American listing standards